sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Lytham Partners Healthcare Summit
Jaguar Health, Inc. (NASDAQ: JAGX) announced that its founder, president, and CEO, Lisa Conte, will present virtually at the Lytham Partners Healthcare Investor Summit on January 15, 2026. The presentation is scheduled for 3:30 PM Eastern and will offer updates on Jaguar Health's near-term catalysts. A replay will be accessible through the designated conference link.
Jaguar Health is a commercial stage pharmaceutical company focused on developing prescription medicines derived from rainforest plants. These products target gastrointestinal distress, including conditions such as chronic diarrhea and bowel incontinence. The company's subsidiary, Napo Pharmaceuticals, markets crofelemer, an FDA-approved treatment for noninfectious diarrhea in adults with HIV/AIDS.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.